Back to Subject Index | Return to Arthritis & Rheumatism Table of Contents Page

• Naive T cells, in SLE-associated glomerulonephritis, 335
• Neck injury, and chronic pain syndrome, 758
• Necrotizing vasculitis
  • nasal, 1437
  • nonsystemic, of peripheral nervous system, 1324
• Needle biopsy, measuring inflammation in RA synovial tissue, 663
• Neoepitopes, in antigen-induced arthritis, interleukin-1 regulation of matrix metalloproteinase-induced, 647
• Neoplasms, intravascular lymphoma presenting as symmetric polyarthritis, 1127
• Neuropathy, subclinical peripheral, in RA, 1196
• Neuropsychiatric SLE, 739, 745
• Nitric oxide (NO)
  • in experimental OA, apoptosis and, 1266
  • in inflammation and immunity, 1141
  • in murine experimental arthritis, 634
  • in OA, synthase inhibition and progression reduction, 1275
  • in OA chondrocytes, synthase expression, 2165
  • in RA, reduced overexpression, induced by anti-tumor necrosis factor α monoclonal antibody, 2205
• Nitric oxide synthase, 2165, 2205
• Nociception, altered, after spinal injury, versus fibromyalgia, 183
• NOD-derived murine model of primary SS, 150
• Nonsteroidal antiinflammatory drugs (NSAIDs)
  • misoprostol and, 16
  • in oligoarthritis associated with acne and pustulosis, 1889
  • in SSc renal crisis, 1613
  • vascular cell adhesion molecule 1/very late activation antigen-mediated lymphocyte cell adhesion, 1677
• N-telopeptide breakdown products (NTX), type I collagen, in Paget's disease, 354
• Nuclear factor [gk]B/p50
  • activation of distal metalloproteinase-1 promoter, 1987
  • Tax protein activation of synovial cells, 1995
• NZM2410 lupus-prone mice, expanded splenic B1a cells in, 1652